Literature DB >> 10994871

Oxidation of tryptophan by redox intermediates of myeloperoxidase and inhibition of hypochlorous acid production.

A J Kettle1, L P Candaeis.   

Abstract

The neutrophil enzyme myeloperoxidase catalyzes the oxidation of tyrosine to tyrosyl radicals, which cross-link to proteins and initiate lipid peroxidation. Tryptophan is present in plasma at about the same concentration as tyrosine and has a similar one-electron reduction potential. In this investigation, we have determined the ability of myeloperoxidase to catalyze the oxidation of tryptophan to assess whether or not this reaction may contribute to oxidative stress at sites of inflammation. We show that tryptophan is a poor substrate for myeloperoxidase because, even though it reacts rapidly with compound I (kI 2.1 x 10(6) M(-1)s(-1)), it reacts sluggishly with compound II (kII 7 M(-1)s(-1)). Tryptophan reversibly inhibited production of hypochlorous acid by purified myeloperoxidase by converting the enzyme to a mixture of compound II and compound III. It gave 50% inhibition (I50) at a concentration of 2 microM. In contrast, it was an ineffective inhibitor of hypochlorous acid production by human neutrophils (I50 80 microM) unless superoxide dismutase was present (I50 5 microM). We propose that compound I of myeloperoxidase will oxidize tryptophan at sites of inflammation. Enzyme turnover will result from the reaction of superoxide or tyrosine with compound II. Thus, tryptophan radicals are potential candidates for exacerbating oxidative stress during inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994871     DOI: 10.1179/135100000101535726

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  7 in total

1.  Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation.

Authors:  Flavia C Meotti; Guy N L Jameson; Rufus Turner; D Tim Harwood; Samantha Stockwell; Martin D Rees; Shane R Thomas; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

2.  Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase.

Authors:  Semira Galijasevic; Ibrahim Abdulhamid; Husam M Abu-Soud
Journal:  Free Radic Biol Med       Date:  2008-01-18       Impact factor: 7.376

3.  Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.

Authors:  Mohammed Freewan; Martin D Rees; Tito S Sempértegui Plaza; Elias Glaros; Yean J Lim; Xiao Suo Wang; Amanda W S Yeung; Paul K Witting; Andrew C Terentis; Shane R Thomas
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

Review 4.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

5.  Specific sequence motifs direct the oxygenation and chlorination of tryptophan by myeloperoxidase.

Authors:  Xiaoyun Fu; Yi Wang; Jeffery Kao; Angela Irwin; André d'Avignon; Robert P Mecham; William C Parks; Jay W Heinecke
Journal:  Biochemistry       Date:  2006-03-28       Impact factor: 3.162

6.  N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.

Authors:  Hao Zhang; Xigang Jing; Yang Shi; Hao Xu; Jianhai Du; Tongju Guan; Dorothee Weihrauch; Deron W Jones; Weiling Wang; David Gourlay; Keith T Oldham; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  J Lipid Res       Date:  2013-07-24       Impact factor: 5.922

7.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.